Title: Optimisation of molecular testing in newly-diagnosed acute myeloid leukaemia (AML) in Wales
Funder
Novartis Pharmaceuticals UK Ltd
Principal Investigator
Project Details
Net value award figure for Cardiff University: £130,000.00
Start date: 01/06/2019
End date: 31/12/2021
